47th FEBS Congress, Tours, Fransa, 8 - 12 Temmuz 2023, cilt.13, ss.245-246
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized
by progressive fibrosis. The precise mechanisms of SSc
remain poorly understood. NLRP3 inflammasome is a key player
in regulating host immune responses to infection. NLRP3 inflammasome
activation is associated with autoimmune rheumatic diseases.
Once NLRP3 is activated, NLRP3 interacts with NEK7,
then recruits ASC and caspase-1 assembling into NLRP3 inflammasome,
which leads to maturation and excretion of proinflammatory
cytokines IL-1b and IL-18. The link between NLRP3
inflammasome activation and SSc pathogenesis has recently been
established. The aim of this study is to investigate gene expression
levels of NEK7, caspase-1, IL-1b, IL-18, and type I collagen
a1 chain (COL1A1) in the dermal fibroblasts of SSc patients.
Nine patients with SSc and 3 healthy controls were enrolled in
the study after they signed a written informed consent form. We
obtained punch biopsy samples of the affected skin over the dorsal
mid-forearm from each individual. Dermal fibroblasts were
prepared from skin samples of SSc patients and healthy controls.
Total RNA was isolated from cells and cDNA synthesis was performed.
The mRNA expression levels of NEK7, IL-1b, IL-18,
caspase-1 and COL1A1 were measured by qPCR. Quantification
of gene expression was calculated using the DDCt method. Our
results showed that mRNA levels of IL-1b and IL-18 were significantly
increased in the dermal fibroblasts of SSc patients compared
with healthy controls. COL1A1 mRNA level was also
significantly increased in SSc patients compared with healthy
controls showing skin fibrosis in patients. Although NEK7 and
caspase-1 mRNA levels were higher in dermal fibroblasts of SSc
patients compared with controls, no significant difference was
found between groups. Our results demonstrate that IL-1b, IL-18 and COL1A1 mRNA levels were increased in the dermal fibroblasts
of SSc patients suggesting the important role of NLRP3
inflammasome activation in the pathogenesis of SSc.